NCT02100917View on ClinicalTrials.gov

Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

DMB-3111

DRUG

trastuzumab

Trial Locations (1)

Unknown

Fukuoka

Sponsors

Collaborators (1)

Dong-A Pharmaceutical
All Listed Sponsors
collaborator

Dong-A Pharmaceutical

INDUSTRY

lead

Meiji Seika Pharma Co., Ltd.

INDUSTRY